- Home
- BPMC vs VRNS Comparison
BPMC vs VRNS Comparison
Compare BPMC & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- VRNS
- Stock Information
- Founded
- BPMC 2008
- VRNS 2004
- Country
- BPMC United States
- VRNS United States
- Employees
- BPMC N/A
- VRNS N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- VRNS Computer Software: Prepackaged Software
- Sector
- BPMC Health Care
- VRNS Technology
- Exchange
- BPMC Nasdaq
- VRNS Nasdaq
- Market Cap
- BPMC 5.8B
- VRNS 4.4B
- IPO Year
- BPMC 2015
- VRNS 2014
- Fundamental
- Price
- BPMC $97.17
- VRNS $45.30
- Analyst Decision
- BPMC Buy
- VRNS Buy
- Analyst Count
- BPMC 21
- VRNS 18
- Target Price
- BPMC $124.05
- VRNS $55.35
- AVG Volume (30 Days)
- BPMC 973.2K
- VRNS 1.2M
- Earning Date
- BPMC 05-01-2025
- VRNS 05-06-2025
- Dividend Yield
- BPMC N/A
- VRNS N/A
- EPS Growth
- BPMC N/A
- VRNS N/A
- EPS
- BPMC N/A
- VRNS N/A
- Revenue
- BPMC $562,121,000.00
- VRNS $573,351,000.00
- Revenue This Year
- BPMC $44.85
- VRNS $14.84
- Revenue Next Year
- BPMC $32.06
- VRNS $16.13
- P/E Ratio
- BPMC N/A
- VRNS N/A
- Revenue Growth
- BPMC 99.19
- VRNS 13.35
- 52 Week Low
- BPMC $73.04
- VRNS $36.53
- 52 Week High
- BPMC $121.90
- VRNS $60.58
- Technical
- Relative Strength Index (RSI)
- BPMC 59.54
- VRNS 69.58
- Support Level
- BPMC $87.03
- VRNS $42.75
- Resistance Level
- BPMC $104.86
- VRNS $46.57
- Average True Range (ATR)
- BPMC 3.86
- VRNS 1.11
- MACD
- BPMC 1.24
- VRNS 0.41
- Stochastic Oscillator
- BPMC 64.38
- VRNS 81.25
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.